Panelists discuss how healthcare resource utilization is primarily driven by hospitalizations, medication costs, and ...

There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.

The Cardiac Centre at Al Qassimi Hospital, operated by Emirates Health Services (EHS), has become the first facility in the ...

Hypertension affects 1 in 3 adults globally and is the leading modifiable risk factor for cardiovascular disease. Aldosterone ...

Merck (MRK) stock in focus as its lung disease drug Winrevair gains FDA priority review for a label update based on Phase 3 ...

Merck's Winrevair gains FDA priority review for PAH label update after ZENITH trial shows major reduction in serious events and strong clinical impact.

Hypertension is high blood pressure. It is generally defined in adults as systolic blood pressure greater than or equal to 140mmHg and/or diastolic blood pressure greater than or equal to 90mmHg.

Exercise-induced hypertension, also called hypertensive response to exercise (HRE), is a condition in which your blood pressure spikes dramatically during physical activity. It’s unclear how ...

PAH patients with cardiovascular disease risk had similar hospitalization and mortality rates as those without after a ...

NT-proCNP as a new biomarker of pulmonary hypertension in patients with COPD Sergey N. Avdeev Viliya V. Gaynitdinova Qingyun Ma Research Open Access 01 Jul 2025 Scientific Reports Volume: 15, P: 21169 ...

The UK medicines regulator has awarded Alnylam's RNAi-based therapy zilebesiran for hypertension an 'innovation passport', a designation designed to speed up NHS access to promising new medicines ...

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study ...